📰 John Power News
Page 41 - John Power News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from John Power. Real-time updates on events, politics, business and more.
November 22, 2021
/CNW/ - Digital technology is changing how we access information, work, and connect with each other. With more of our interactions taking place online than...
November 5, 2021
/CNW Telbec/ - Innovation, Science and Economic Development Canada Today, François-Philippe Champagne, Canadas Minister of Innovation, Science and Industry,...
November 5, 2021
/CNW/ - Canadians are more connected than ever before, and they rely on telecommunications services to be connected at work, school and home. Access to...
November 4, 2021
/CNW/ - Innovation, Science and Economic Development Canada Today, François-Philippe Champagne, Canadas Minister of Innovation, Science and Industry, and Gina...
November 4, 2021
/CNW/ - Innovation, Science and Economic Development Canada The Government of Canada is looking for innovative ways to help Canadian small businesses succeed....
November 4, 2021
/CNW Telbec/ - Innovation, Science and Economic Development Canada The Government of Canada is looking for innovative ways to help Canadian small businesses...
November 3, 2021
/CNW/ - Canadas cleantech entrepreneurs are proving their power to take on todays environmental challenges. Working in partnership with innovative companies,...
November 2, 2021
Biotechnology company Novavax Inc. says it has submitted its COVID-19 vaccine for approval in Canada, opening the prospect of another product on the country's vaccine market that could win over a few more vaccine-hesitant residents. The U.S.
November 1, 2021
Biotechnology company Novavax Inc. says it has submitted its COVID-19 vaccine for approval in Canada, opening the prospect of another product on the country's vaccine market that could win over a few more vaccine-hesitant residents. The U.S.
November 1, 2021
Biotechnology company Novavax Inc. says it has submitted its COVID-19 vaccine for approval in Canada, opening the prospect of another product on the country's vaccine market that could win over a few more vaccine-hesitant residents. The U.S.